| In Case
Against Quincy Bioscience FTC Admits
Cannot Seek Monetary Relief in SDNY
By Matthew
Russell Lee, Patreon
BBC
- Guardian
UK - Honduras
- ESPN
SDNY COURTHOUSE,
Sept 17 – Back in 2017 the FTC
and New York State's then-AG
Eric Schneiderman sued Quincy
Bioscience Holding
Company for fraudulent
marketing of the dietary
supplement
Prevagen.
On September 17 U.S. District
Court for the Southern
District of New York Judge
Louis L. Stanton held a
proceeding. Inner City Press
covered it.
Judge Stanton asked why there
should be motion practice if
there was no dispute or
opposition.
The FTC, under
current law, cannot get
monetary relief. After some
back and forth it was agreed,
and then ordered: the FTC's
claim for monetary relief is
dismissed without prejudice
and with leave to renew and to
seek such relief if the
applicable law, as set forth
in AMG Capital Mgmt., LLC v.
FTC, 141 S. Ct. 1341 (2021)
were to be changed to allow
such a recovery.
The case is
Federal Trade Commission et
al. v. Quincy Bioscience
Holding Company, Inc. et al.,
17-cv-124 (Stanton)
***
Your
support means a lot. As little as $5 a month
helps keep us going and grants you access to
exclusive bonus material on our Patreon
page. Click
here to become a patron.
Feedback:
Editorial [at] innercitypress.com
SDNY Press Room 480, front cubicle
500 Pearl Street, NY NY 10007 USA
Mail: Box 20047, Dag
Hammarskjold Station NY NY 10017
Reporter's mobile (and weekends):
718-716-3540
Other, earlier Inner City Press are
listed here,
and some are available in the ProQuest
service, and now on Lexis-Nexis.
Copyright 2006-2021 Inner City
Press, Inc. To request reprint or other
permission, e-contact Editorial [at]
innercitypress.com
|
,
